These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24402955)

  • 21. Anticancer drug discovery in the future: an evolutionary perspective.
    Ma X; Wang Z
    Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.
    Yamori T
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S74-9. PubMed ID: 12819939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facilitating patient-centered cancer research and a new era of drug discovery.
    Niederhuber JE
    Oncologist; 2009 Apr; 14(4):311-2. PubMed ID: 19365096
    [No Abstract]   [Full Text] [Related]  

  • 24. Prediction of drug efficacy for cancer treatment based on comparative analysis of chemosensitivity and gene expression data.
    Wan P; Li Q; Larsen JE; Eklund AC; Parlesak A; Rigina O; Nielsen SJ; Björkling F; Jónsdóttir SÓ
    Bioorg Med Chem; 2012 Jan; 20(1):167-76. PubMed ID: 22154557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical approaches to the discovery and development of cancer therapies.
    Neidle S; Thurston DE
    Nat Rev Cancer; 2005 Apr; 5(4):285-96. PubMed ID: 15803155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer Institute.
    Trimble EL; Abrams JS; Ansher SS; Smith MA; Zwiebel JA; Tomaszewski JE
    Future Med Chem; 2010 Apr; 2(4):555-9. PubMed ID: 21426005
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.
    Hohman M; Gregory K; Chibale K; Smith PJ; Ekins S; Bunin B
    Drug Discov Today; 2009 Mar; 14(5-6):261-70. PubMed ID: 19231313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of novel drugs for promising targets.
    Martell RE; Brooks DG; Wang Y; Wilcoxen K
    Clin Ther; 2013 Sep; 35(9):1271-81. PubMed ID: 24054704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Front-line drug discovery system for cancer].
    Mizukami T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomics and cancer drug discovery: let the cells do the talking.
    D'Alessandro A; Zolla L
    Drug Discov Today; 2012 Jan; 17(1-2):3-9. PubMed ID: 22001601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHMIS-C: a comprehensive herbal medicine information system for cancer.
    Fang X; Shao L; Zhang H; Wang S
    J Med Chem; 2005 Mar; 48(5):1481-8. PubMed ID: 15743190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute.
    Marum L
    Future Med Chem; 2012 May; 4(8):947. PubMed ID: 22826900
    [No Abstract]   [Full Text] [Related]  

  • 34. Exploring the biologically relevant chemical space for drug discovery.
    Deng ZL; Du CX; Li X; Hu B; Kuang ZK; Wang R; Feng SY; Zhang HY; Kong DX
    J Chem Inf Model; 2013 Nov; 53(11):2820-8. PubMed ID: 24125686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research spotlight: The Cooperative Research Centre for Cancer Therapeutics: bridging the gap between leading cancer research at Australia's universities and developing novel cancer drugs.
    Baell JB; Heathers G; Sage C
    Future Med Chem; 2010 Jun; 2(6):941-7. PubMed ID: 21426113
    [No Abstract]   [Full Text] [Related]  

  • 36. The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow.
    Pors K; Goldberg FW; Leamon CP; Rigby AC; Snyder SA; Falconer RA
    Drug Discov Today; 2009 Nov; 14(21-22):1045-50. PubMed ID: 19638319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology.
    Cheung-Ong K; Giaever G; Nislow C
    Chem Biol; 2013 May; 20(5):648-59. PubMed ID: 23706631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemistry's web of data expands.
    Van Noorden R
    Nature; 2012 Mar; 483(7391):524. PubMed ID: 22460877
    [No Abstract]   [Full Text] [Related]  

  • 39. The preclinical new drug research program of the National Cancer Institute.
    Driscoll JS
    Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bypassing phase 1 trials in the cancer drug development paradigm: generally unwise and potentially dangerous.
    Markman M
    Cancer; 2010 Nov; 116(22):5116-8. PubMed ID: 20665504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.